Common metabolic drug helps memory in mice

Share this article:
A drug that has until now been prescribed to treat patients with a certain metabolic disorder has been found to improve the memory of laboratory animals with Alzheimer's disease, according to a recent report.

Sodium phenylbutyrate is commonly used to treat patients who experience an alteration in the urea cycle. Researchers discovered that the drug also helped certain proteins, which are responsible for neuron connections, fuse together, resulting in improved learning capacity of lab mice. Researchers at the Center for Applied Medical Research (CIMA) at the University of Navarra are investigating which element of the drug is responsible for the beneficial effects.

Because sodium phenylbutyrate is already available for use, researchers suggest it could potentially be used to treat Alzheimer's and other dementia patients much sooner than other experimental drugs. The report was published in the journal Neuropsychopharmacology.
Share this article:

More in News

Long-term care leaders need self-awareness, partnerships to avoid the 'Founder's Trap,' CEO panel advises

Long-term care leaders need self-awareness, partnerships to avoid ...

Strong leaders must be vigilant or they could stifle a company's innovation and growth, a CEO panel said Monday at the 2014 LINK LTC and Senior Living Conference in Chicago.

Coaching sessions reduce hospital readmissions, study finds

An hour-long educational coaching session and up to three follow-up phone calls reduced readmissions by 39% among Medicare patients, a new study finds.

County nursing home weighs heroin addict plan

An Ohio county is evaluating whether 20 beds at its nursing home could be dedicated for heroin addicts during their withdrawal, according to local reports.